Identification of a Dual Functional Betulinic Acid Analog for the Treatment of Osteoarthritis by Phenotypic Screening
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Arnst J, Jing Z, Cohen C, Ha S, Viggeswarapu M, Beck Jr G
. Bioactive silica nanoparticles target autophagy, NF-κB, and MAPK pathways to inhibit osteoclastogenesis. Biomaterials. 2023; 301:122238.
PMC: 10530178.
DOI: 10.1016/j.biomaterials.2023.122238.
View
2.
Chen F, Jiang G, Liu H, Li Z, Pei Y, Wang H
. Melatonin alleviates intervertebral disc degeneration by disrupting the IL-1β/NF-κB-NLRP3 inflammasome positive feedback loop. Bone Res. 2020; 8:10.
PMC: 7028926.
DOI: 10.1038/s41413-020-0087-2.
View
3.
Gowers G, Chee S, Bell D, Suckling L, Kern M, Tew D
. Improved betulinic acid biosynthesis using synthetic yeast chromosome recombination and semi-automated rapid LC-MS screening. Nat Commun. 2020; 11(1):868.
PMC: 7018806.
DOI: 10.1038/s41467-020-14708-z.
View
4.
Katz J, Arant K, Loeser R
. Diagnosis and Treatment of Hip and Knee Osteoarthritis: A Review. JAMA. 2021; 325(6):568-578.
PMC: 8225295.
DOI: 10.1001/jama.2020.22171.
View
5.
Vincent F, Nueda A, Lee J, Schenone M, Prunotto M, Mercola M
. Phenotypic drug discovery: recent successes, lessons learned and new directions. Nat Rev Drug Discov. 2022; 21(12):899-914.
PMC: 9708951.
DOI: 10.1038/s41573-022-00472-w.
View